Search for

 

1209 results found

Banning psychoactive substances is not enough, we need education too

The Psychoactive Substances Act 2016 Novel Psychoactive Substances (NPSs), also referred to as ‘legal highs’, represent a bewildering array of unregulated psychoactive compounds, marketed globally as legal alternatives to well-known controlled drugs. More than 40 years ago...

Join us for industry and academic insights on new drug modalities

ELRIG and the British Pharmacological Society are teaming up to bring you our New Modalities in Pharmacology and Drug Discovery event on 4-5 July 2022 at the Francis Crick Institute, London. At this cutting-edge event, you will have the opportunity to join researcher...

An interview with 2022's journal ECR prizewinners

The British Journal of Pharmacology (BJP) and the British Journal of Clinical Pharmacology (BJCP) award annual prizes for the best papers published by early career researchers over the previous year. Awardees receive a cash prize, a certificate and one year of complimenta...

Beyond the powerhouse: mitochondrial DNA and drug safety

If there’s one thing that people remember from biology at school, it’s that mitochondria are the powerhouses of the cell. They’re not wrong – in fact, every day the average healthy human produces their bodyweight in the cellular energy currency ATP , and 90 % of this is gen...

Can’t you just feel that release of endorphins?

Almost everyone nowadays knows about endorphins, brain neurotransmitters whose release is invariably invoked when someone is describing the sensation of pleasure. But few know that the first endorphins were isolated and characterised at the Unit for Research on Addictive Drug...

Society responds to Remdesivir trials announcement

The Society has responded to the announcement that Gilead Sciences will initiate two phase 3 randomised studies to evaluate the safety and antiviral activity of remdesivir in participants with moderate to severe COVID-19. Professor Sir Munir Pirmohamed, the Society's Presid...

Society supports call that visas for international scientists must be competitively costed

Today, the Society has joined partner organisations in the UK research and innovation sector in calling for competitively costed visas for international scientists. The call comes ahead of the Immigration Bill passing to Committee Stage in the House of Commons on 9 June 2020...

A guide to organising your first conference

Despite attending many conferences during our time in academia, the work that goes into organising these events remained a mystery. When the call for proposals for the Young Life Scientists’ (YLS) symposium came out, we thought it would be a great opportunity to see things fr...

Investing in UK clinical pharmacology will save and improve lives

The Society, as part of the Clinical Pharmacology Skills Alliance (CPSA), today welcomes the UK-wide government vision -  Saving and improving lives: the future of UK clinical research delivery - that aims “to create a patient-centred, pro-innovation and digitally enabl...

A growing rep and curing strep – the rise of community pharmacy

‘A growing rep and curing strep – the rise of community pharmacy’ is the 2021 winning article from our annual writing competition for early career pharmacologists. It was written by Abbie Thomas from Swansea University Medical School. Our judges enjoyed Abbie’s submission’s f...